{"id":"https://openalex.org/W2065323675","doi":"https://doi.org/10.1016/0278-5846(83)90043-x","title":"New concepts in benzodiazepine therapy: Rebound anxiety and new indications for the more potent benzodiazepines","display_name":"New concepts in benzodiazepine therapy: Rebound anxiety and new indications for the more potent benzodiazepines","publication_year":1983,"publication_date":"1983-01-01","ids":{"openalex":"https://openalex.org/W2065323675","doi":"https://doi.org/10.1016/0278-5846(83)90043-x","mag":"2065323675","pmid":"https://pubmed.ncbi.nlm.nih.gov/6141609"},"language":"en","primary_location":{"id":"doi:10.1016/0278-5846(83)90043-x","doi":"https://doi.org/10.1016/0278-5846(83)90043-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0278-5846(83)90043-x","pdf_url":null,"source":{"id":"https://openalex.org/S142279999","display_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","issn_l":"0278-5846","issn":["0278-5846","1878-4216"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110419096","display_name":"Guy Chouinard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130461","display_name":"Institut universitaire en sant\u00e9 mentale de Montr\u00e9al","ror":"https://ror.org/02twt6343","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210130461"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Guy Chouinard","raw_affiliation_strings":["Clinical Psychopharmacology Unit, Allan Memorial Institute Department of Psychiatry, McGill University, and Research Department, Louis-H. Lafontaine Hospital, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Allan Memorial Institute Department of Psychiatry, McGill University, and Research Department, Louis-H. Lafontaine Hospital, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4210130461","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anne Labonte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130461","display_name":"Institut universitaire en sant\u00e9 mentale de Montr\u00e9al","ror":"https://ror.org/02twt6343","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210130461"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Anne Labonte","raw_affiliation_strings":["Clinical Psychopharmacology Unit, Allan Memorial Institute Department of Psychiatry, McGill University, and Research Department, Louis-H. Lafontaine Hospital, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Allan Memorial Institute Department of Psychiatry, McGill University, and Research Department, Louis-H. Lafontaine Hospital, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4210130461","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rejean Fontaine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130461","display_name":"Institut universitaire en sant\u00e9 mentale de Montr\u00e9al","ror":"https://ror.org/02twt6343","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210130461"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Rejean Fontaine","raw_affiliation_strings":["Clinical Psychopharmacology Unit, Allan Memorial Institute Department of Psychiatry, McGill University, and Research Department, Louis-H. Lafontaine Hospital, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Allan Memorial Institute Department of Psychiatry, McGill University, and Research Department, Louis-H. Lafontaine Hospital, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4210130461","https://openalex.org/I5023651"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076932433","display_name":"Lawrence Annable","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130461","display_name":"Institut universitaire en sant\u00e9 mentale de Montr\u00e9al","ror":"https://ror.org/02twt6343","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210130461"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lawrence Annable","raw_affiliation_strings":["Clinical Psychopharmacology Unit, Allan Memorial Institute Department of Psychiatry, McGill University, and Research Department, Louis-H. Lafontaine Hospital, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Unit, Allan Memorial Institute Department of Psychiatry, McGill University, and Research Department, Louis-H. Lafontaine Hospital, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I4210130461","https://openalex.org/I5023651"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4380,"currency":"USD","value_usd":4380},"apc_paid":null,"fwci":2.2314,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.89957697,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"7","issue":"4-6","first_page":"669","last_page":"673"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.953000009059906},{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal","display_name":"benzodiazepine withdrawal","score":0.9190000295639038},{"id":"https://openalex.org/keywords/alprazolam","display_name":"alprazolam","score":0.9169999957084656},{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bromazepam","display_name":"bromazepam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.7390000224113464},{"id":"https://openalex.org/keywords/manic-symptoms","display_name":"manic symptoms","score":0.7149999737739563},{"id":"https://openalex.org/keywords/lithium","display_name":"lithium","score":0.7720000147819519},{"id":"https://openalex.org/keywords/generalized-anxiety-disorder","display_name":"generalized anxiety disorder","score":0.9829999804496765},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.7260000109672546},{"id":"https://openalex.org/keywords/anxiolytic-efficacy","display_name":"anxiolytic efficacy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/triazolobenzodiazepines","display_name":"triazolobenzodiazepines","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.9553558826446533},{"id":"https://openalex.org/C2778519950","wikidata":"https://www.wikidata.org/wiki/Q422435","display_name":"Bromazepam","level":4,"score":0.9494876265525818},{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.9494471549987793},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.8391962051391602},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.6652650833129883},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.656599760055542},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.621122419834137},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.5821709632873535},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.5714662671089172},{"id":"https://openalex.org/C2909738485","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anti-Anxiety Agents","level":3,"score":0.5633863806724548},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.5476700663566589},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.47900813817977905},{"id":"https://openalex.org/C2778678127","wikidata":"https://www.wikidata.org/wiki/Q174589","display_name":"Agoraphobia","level":4,"score":0.47842341661453247},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4409993588924408},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4393296539783478},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37118005752563477},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.32405781745910645},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3122999668121338},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2198367714881897},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.08286908268928528},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000525","descriptor_name":"Alprazolam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001960","descriptor_name":"Bromazepam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002998","descriptor_name":"Clonazepam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010200","descriptor_name":"Panic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011956","descriptor_name":"Receptors, Cell Surface","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/0278-5846(83)90043-x","doi":"https://doi.org/10.1016/0278-5846(83)90043-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0278-5846(83)90043-x","pdf_url":null,"source":{"id":"https://openalex.org/S142279999","display_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","issn_l":"0278-5846","issn":["0278-5846","1878-4216"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","raw_type":"journal-article"},{"id":"pmid:6141609","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6141609","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progress in neuro-psychopharmacology & biological psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W155179578","https://openalex.org/W1890987751","https://openalex.org/W1967795096","https://openalex.org/W1970762847","https://openalex.org/W1980904592","https://openalex.org/W2049165791","https://openalex.org/W2060498376","https://openalex.org/W2069644518","https://openalex.org/W2071036162","https://openalex.org/W2094475989","https://openalex.org/W2397351380","https://openalex.org/W2400301953","https://openalex.org/W2406846809","https://openalex.org/W2413258150","https://openalex.org/W2417357511","https://openalex.org/W2418101390","https://openalex.org/W3036862357","https://openalex.org/W4300833494","https://openalex.org/W6662412540","https://openalex.org/W6712248468"],"related_works":["https://openalex.org/W179626809","https://openalex.org/W1982259566","https://openalex.org/W1518214111","https://openalex.org/W1705744169","https://openalex.org/W9329606","https://openalex.org/W95041057","https://openalex.org/W2417689765","https://openalex.org/W2065747869","https://openalex.org/W164852580","https://openalex.org/W154086589"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}